Back

The effect of empagliflozin on ketone bodies in patients with heart failure with reduced ejection fraction (Empire HF)

26 August 2023 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: New pathophysiological insights of heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Massar Omar

Odense University Hospital, Odense (Denmark)

5 More presentations in this session

Presentation thumbnail
Myocardial DNA damage combined with genotype predicts heart failure outcome in various underlying diseases
Doctor Z. Dai (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Interleukin 17A-correlated myocarditis in patients with psoriasis: cardiac recovery following secukinumab administration
Doctor A. Frustaci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Pathophysiological role of epicardial adipose tissue and its phenotypes in patients with diabetes and cardiovascular comorbidities.
Doctor S. Kotha (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial.
Doctor M. Del Bene (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction: a translational study
Doctor E. Gorica (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
New pathophysiological insights of heart failure
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic effects of 14-day oral ketone ester treatment in patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Beneficial metabolic effects of 2-week ketone ester in patients with type 2 diabetes and heart failure with preserved ejection fraction.
thumbnail
Congress Presentation
European Heart Journal

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources